CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Celltrion, Incorporation Company Snapshot
Celltrion, Incorporation operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Celltrion, Incorporation with three other companies in this sector in South Korea: Samsung Biologics Co Ltd (2017 sales of 464.63 billion Korean Won [US$411.66 million] of which 100% was Biological Medicine Production), Green Cross Corporation (1.29 trillion Korean Won [US$1.14 billion] of which 85% was Greencross), and Celltrion HealthCare Co Ltd (920.92 billion Korean Won [US$815.94 million] ).

Sales Analysis. Celltrion, Incorporation reported sales of 949.08 billion Korean Won (US$840.88 million) for the year ending December of 2017. This represents an increase of 41.5% versus 2016, when the company's sales were 670.58 billion Korean Won. This was the fourth straight year of sales growth at Celltrion, Incorporation. Sales of Bio Business Division saw an increase of 43.5% in 2017, from 577.57 billion Korean Won to 828.92 billion Korean Won. Not all segments of Celltrion, Incorporation experienced an increase in sales in 2017: sales of Other Segment fell 0.7% to 8.84 billion Korean Won. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Celltrion, Incorporation
  Stock Performance Chart for Celltrion, Incorporation
 
  Stock Data: Recent Stock Performance:
  Current Price (8/10/2018): 272,000
(Figures in Korean Won)
1 Week -3.0%   13 Weeks -5.6%  
4 Weeks 4.6%   52 Weeks 166.8%  
 
Celltrion, Incorporation Key Data:
  Ticker: 068270 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2017 Sales 949,079,965,214
(Year Ending Jan 2018).
Employees: 1,074
  Currency: Korean Won Market Cap: 33,941,698,160,000
  Fiscal Yr Ends: December Shares Outstanding: 124,785,655
  Share Type: Common Closely Held Shares: 45,269,068
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.